The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma

Colon adenocarcinoma (COAD) is one of the most common clinically malignant tumours of the digestive system, with high incidence and mortality and poor prognosis. Interferon-gamma (IFN-γ) and long noncoding RNAs (lncRNAs) have prognostic values and were closely associated with immune microenvironment...

Full description

Bibliographic Details
Main Authors: Cong Liu, Dingwei Liu, Fangfei Wang, Jun Xie, Yang Liu, Huan Wang, Jianfang Rong, Jinliang Xie, Jinyun Wang, Rong Zeng, Yong Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.876660/full
_version_ 1818549309917888512
author Cong Liu
Cong Liu
Cong Liu
Dingwei Liu
Dingwei Liu
Dingwei Liu
Fangfei Wang
Fangfei Wang
Fangfei Wang
Jun Xie
Jun Xie
Jun Xie
Yang Liu
Yang Liu
Yang Liu
Huan Wang
Huan Wang
Huan Wang
Jianfang Rong
Jianfang Rong
Jianfang Rong
Jinliang Xie
Jinliang Xie
Jinliang Xie
Jinyun Wang
Jinyun Wang
Jinyun Wang
Rong Zeng
Rong Zeng
Rong Zeng
Yong Xie
Yong Xie
Yong Xie
author_facet Cong Liu
Cong Liu
Cong Liu
Dingwei Liu
Dingwei Liu
Dingwei Liu
Fangfei Wang
Fangfei Wang
Fangfei Wang
Jun Xie
Jun Xie
Jun Xie
Yang Liu
Yang Liu
Yang Liu
Huan Wang
Huan Wang
Huan Wang
Jianfang Rong
Jianfang Rong
Jianfang Rong
Jinliang Xie
Jinliang Xie
Jinliang Xie
Jinyun Wang
Jinyun Wang
Jinyun Wang
Rong Zeng
Rong Zeng
Rong Zeng
Yong Xie
Yong Xie
Yong Xie
author_sort Cong Liu
collection DOAJ
description Colon adenocarcinoma (COAD) is one of the most common clinically malignant tumours of the digestive system, with high incidence and mortality and poor prognosis. Interferon-gamma (IFN-γ) and long noncoding RNAs (lncRNAs) have prognostic values and were closely associated with immune microenvironment in COAD. Thus, identifying IFN-γ-related lncRNAs may be valuable in predicting the survival of patients with COAD. In this study, we identified IFN-γ-related lncRNAs and divided COAD patients from the Cancer Genome Atlas (TCGA) database into training and validation sets. Pearson’s correlation analysis and least absolute shrinkage and selection operator (LASSO) Cox regression were performed to select IFN-γ-related lncRNA-associated prognoses. Thirteen lncRNAs (AC025165.8, AC091633.3, FENDRR, LINC00882, LINC01828, LINC01829, MYOSLID, RP11-154H23.4, RP11-20J15.3, RP11-324L17.1, RP11-342A23.2, RP11-805I24.3, SERTAD4-AS1) were identified to construct an IFN-γ-related lncRNA prognostic signature in TCGA training (n =213) and validation (n =213) cohorts. COAD patient risk scores were calculated and classified into high- and low-risk groups based on the median value of the risk scores in each dataset. We compared the overall survival (OS) of patients stratified by age, gender, and stage. The OS in the high-risk group was significantly shorter than that in the low-risk group. In addition, the clinical nomogram incorporating the prognostic signature and clinical features showed a high concordance index of 0.78 and accurately predicted 1-, 3-, and 5-year survival times among COAD patients in the high- and low-risk groups. Based on the risk model, the high- and low-risk groups exhibited distinct differences in the immune system by gene set enrichment analysis (GSEA) functional annotation, and differentially expressed genes (DEGs) between the high- and low-risk groups were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. We investigated the expression of multiple immune checkpoint genes in the high- and low-risk groups and plotted Kaplan-Meier survival curves, indicating that immune checkpoint genes, such as LAG3 and PD. L1, STING and TIM 3, were also expressed differently between the two risk groups. Subsequently, there were dramatic differences in mutated genes, SNV (single nucleotide variants) classes, variant types and variant allele frequencies between low- and high-risk patients with COAD. Patients stratified by risk scores had different sensitivities to common chemotherapeutic agents. Finally, we used quantitative real-time polymerase chain reaction (qRT-PCR) assays to demonstrate that three lncRNAs were significantly differentially expressed in COAD tissues and adjacent normal tissues. Considered together, a thirteen-lncRNA prognostic signature has great potential to be a prognostic biomarker and could play an essential role in the immune microenvironment of COAD.
first_indexed 2024-12-12T08:31:41Z
format Article
id doaj.art-95e03b1e0d2a4a74b7ace7e7c4d50a7f
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-12T08:31:41Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-95e03b1e0d2a4a74b7ace7e7c4d50a7f2022-12-22T00:31:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-06-011210.3389/fonc.2022.876660876660The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon AdenocarcinomaCong Liu0Cong Liu1Cong Liu2Dingwei Liu3Dingwei Liu4Dingwei Liu5Fangfei Wang6Fangfei Wang7Fangfei Wang8Jun Xie9Jun Xie10Jun Xie11Yang Liu12Yang Liu13Yang Liu14Huan Wang15Huan Wang16Huan Wang17Jianfang Rong18Jianfang Rong19Jianfang Rong20Jinliang Xie21Jinliang Xie22Jinliang Xie23Jinyun Wang24Jinyun Wang25Jinyun Wang26Rong Zeng27Rong Zeng28Rong Zeng29Yong Xie30Yong Xie31Yong Xie32Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaGastroenterology Institute of Jiangxi Province, Nanchang, ChinaKey Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, ChinaColon adenocarcinoma (COAD) is one of the most common clinically malignant tumours of the digestive system, with high incidence and mortality and poor prognosis. Interferon-gamma (IFN-γ) and long noncoding RNAs (lncRNAs) have prognostic values and were closely associated with immune microenvironment in COAD. Thus, identifying IFN-γ-related lncRNAs may be valuable in predicting the survival of patients with COAD. In this study, we identified IFN-γ-related lncRNAs and divided COAD patients from the Cancer Genome Atlas (TCGA) database into training and validation sets. Pearson’s correlation analysis and least absolute shrinkage and selection operator (LASSO) Cox regression were performed to select IFN-γ-related lncRNA-associated prognoses. Thirteen lncRNAs (AC025165.8, AC091633.3, FENDRR, LINC00882, LINC01828, LINC01829, MYOSLID, RP11-154H23.4, RP11-20J15.3, RP11-324L17.1, RP11-342A23.2, RP11-805I24.3, SERTAD4-AS1) were identified to construct an IFN-γ-related lncRNA prognostic signature in TCGA training (n =213) and validation (n =213) cohorts. COAD patient risk scores were calculated and classified into high- and low-risk groups based on the median value of the risk scores in each dataset. We compared the overall survival (OS) of patients stratified by age, gender, and stage. The OS in the high-risk group was significantly shorter than that in the low-risk group. In addition, the clinical nomogram incorporating the prognostic signature and clinical features showed a high concordance index of 0.78 and accurately predicted 1-, 3-, and 5-year survival times among COAD patients in the high- and low-risk groups. Based on the risk model, the high- and low-risk groups exhibited distinct differences in the immune system by gene set enrichment analysis (GSEA) functional annotation, and differentially expressed genes (DEGs) between the high- and low-risk groups were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. We investigated the expression of multiple immune checkpoint genes in the high- and low-risk groups and plotted Kaplan-Meier survival curves, indicating that immune checkpoint genes, such as LAG3 and PD. L1, STING and TIM 3, were also expressed differently between the two risk groups. Subsequently, there were dramatic differences in mutated genes, SNV (single nucleotide variants) classes, variant types and variant allele frequencies between low- and high-risk patients with COAD. Patients stratified by risk scores had different sensitivities to common chemotherapeutic agents. Finally, we used quantitative real-time polymerase chain reaction (qRT-PCR) assays to demonstrate that three lncRNAs were significantly differentially expressed in COAD tissues and adjacent normal tissues. Considered together, a thirteen-lncRNA prognostic signature has great potential to be a prognostic biomarker and could play an essential role in the immune microenvironment of COAD.https://www.frontiersin.org/articles/10.3389/fonc.2022.876660/fullcolon adenocarcinomalncRNAIFN-γtumour immune microenvironmentprognosis
spellingShingle Cong Liu
Cong Liu
Cong Liu
Dingwei Liu
Dingwei Liu
Dingwei Liu
Fangfei Wang
Fangfei Wang
Fangfei Wang
Jun Xie
Jun Xie
Jun Xie
Yang Liu
Yang Liu
Yang Liu
Huan Wang
Huan Wang
Huan Wang
Jianfang Rong
Jianfang Rong
Jianfang Rong
Jinliang Xie
Jinliang Xie
Jinliang Xie
Jinyun Wang
Jinyun Wang
Jinyun Wang
Rong Zeng
Rong Zeng
Rong Zeng
Yong Xie
Yong Xie
Yong Xie
The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
Frontiers in Oncology
colon adenocarcinoma
lncRNA
IFN-γ
tumour immune microenvironment
prognosis
title The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
title_full The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
title_fullStr The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
title_full_unstemmed The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
title_short The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
title_sort interferon gamma related long noncoding rna signature predicts prognosis and indicates immune microenvironment infiltration in colon adenocarcinoma
topic colon adenocarcinoma
lncRNA
IFN-γ
tumour immune microenvironment
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2022.876660/full
work_keys_str_mv AT congliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT congliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT congliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT dingweiliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT dingweiliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT dingweiliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT fangfeiwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT fangfeiwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT fangfeiwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT junxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT junxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT junxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yangliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yangliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yangliu theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT huanwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT huanwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT huanwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jianfangrong theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jianfangrong theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jianfangrong theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinliangxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinliangxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinliangxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinyunwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinyunwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinyunwang theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT rongzeng theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT rongzeng theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT rongzeng theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yongxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yongxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yongxie theinterferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT congliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT congliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT congliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT dingweiliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT dingweiliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT dingweiliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT fangfeiwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT fangfeiwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT fangfeiwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT junxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT junxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT junxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yangliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yangliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yangliu interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT huanwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT huanwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT huanwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jianfangrong interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jianfangrong interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jianfangrong interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinliangxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinliangxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinliangxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinyunwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinyunwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT jinyunwang interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT rongzeng interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT rongzeng interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT rongzeng interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yongxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yongxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma
AT yongxie interferongammarelatedlongnoncodingrnasignaturepredictsprognosisandindicatesimmunemicroenvironmentinfiltrationincolonadenocarcinoma